When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KPTI - Karyopharm files U.S. application for expanded use of Xpovio
Karyopharm Therapeutics Inc.
Karyopharm Therapeutics (NASDAQ:KPTI) has submitted a supplemental New Drug Application (sNDA) to the FDA seeking approval for XPOVIO (selinexor), an oral Selective Inhibitor of Nuclear Export (SINE) compound, as a new treatment for patients with previously treated multiple myeloma.
More news on: Karyopharm Therapeutics Inc., Healthcare stocks news,